Published in J Cell Biochem on August 01, 2008
Wnt signalling requires MTM-6 and MTM-9 myotubularin lipid-phosphatase function in Wnt-producing cells. EMBO J (2010) 1.02
The inositol phosphatase MTMR4 is a novel target of the ubiquitin ligase Nedd4. Biochem J (2009) 0.83
Myotubularin family phosphatase ceMTM3 is required for muscle maintenance by preventing excessive autophagy in Caenorhabditis elegans. BMC Cell Biol (2012) 0.77
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem (1998) 17.36
Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol (2007) 15.47
Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans. Gene (2001) 11.09
The free radical theory of aging matures. Physiol Rev (1998) 9.83
Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem (2001) 8.47
Protein tyrosine phosphatases in the human genome. Cell (2004) 8.09
Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol (2006) 7.93
The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci U S A (1998) 6.98
A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics (1988) 5.60
Lysosomes and autophagy in cell death control. Nat Rev Cancer (2005) 5.47
A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet (1996) 3.67
Endosomal localization of the autoantigen EEA1 is mediated by a zinc-binding FYVE finger. J Biol Chem (1996) 3.53
Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet (2000) 2.96
Inactivation of the autophagy gene bec-1 triggers apoptotic cell death in C. elegans. Curr Biol (2005) 2.86
Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc Natl Acad Sci U S A (2000) 2.59
Myotubular myopathy. Persistence of fetal muscle in an adolescent boy. Arch Neurol (1966) 2.41
Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum Mol Genet (2003) 2.27
FYVE-finger proteins--effectors of an inositol lipid. J Cell Sci (1999) 2.24
Myotubularin phosphatases: policing 3-phosphoinositides. Trends Cell Biol (2006) 2.09
The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. Proc Natl Acad Sci U S A (2002) 1.91
Effects of aging on muscle fibre type and size. Sports Med (2004) 1.79
Characterization of MTMR3. an inositol lipid 3-phosphatase with novel substrate specificity. Curr Biol (2001) 1.55
Familial "myotubular" myopathy. Neurology (1969) 1.54
The PTEN tumor suppressor homolog in Caenorhabditis elegans regulates longevity and dauer formation in an insulin receptor-like signaling pathway. Proc Natl Acad Sci U S A (1999) 1.52
Disease-related myotubularins function in endocytic traffic in Caenorhabditis elegans. Mol Biol Cell (2003) 1.36
Membrane transport in Caenorhabditis elegans: an essential role for VPS34 at the nuclear membrane. EMBO J (2002) 1.32
Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN. Curr Biol (1999) 1.31
The myotubularin family of lipid phosphatases. Traffic (2005) 1.19
Genetic analysis of the myotubularin family of phosphatases in Caenorhabditis elegans. J Biol Chem (2003) 1.13
FYVE-DSP2, a FYVE domain-containing dual specificity protein phosphatase that dephosphorylates phosphotidylinositol 3-phosphate. Exp Cell Res (2001) 1.11
Oxidative stress and life span determination in the nematode Caenorhabditis elegans. Ann N Y Acad Sci (2002) 1.11
Specific interaction of protein tyrosine phosphatase-MEG2 with phosphatidylserine. J Biol Chem (2003) 0.93
FYVE-DSP1, a dual-specificity protein phosphatase containing an FYVE domain. Biochem Biophys Res Commun (2000) 0.91
Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways. Br J Haematol (2000) 0.90
Identification of an acquired JAK2 mutation in polycythemia vera. J Biol Chem (2005) 5.58
Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice. Blood (2008) 2.37
CD169⁺ macrophages provide a niche promoting erythropoiesis under homeostasis and stress. Nat Med (2013) 2.26
LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. Proc Natl Acad Sci U S A (2009) 1.58
Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth. J Biol Chem (2006) 1.55
Enhanced radiation damage of tumor vasculature by mTOR inhibitors. Oncogene (2005) 1.54
Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy. Oncotarget (2014) 1.51
JAK2(V617F): Prevalence in a large Chinese hospital population. Blood (2006) 1.50
PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal bodies and primary cilia in renal epithelial cells. Proc Natl Acad Sci U S A (2004) 1.42
Survivin as a therapeutic target for radiation sensitization in lung cancer. Cancer Res (2004) 1.33
MAPK-activated protein kinase-2 (MK2)-mediated formation and phosphorylation-regulated dissociation of the signal complex consisting of p38, MK2, Akt, and Hsp27. J Biol Chem (2006) 1.33
Crystal structure of human protein-tyrosine phosphatase SHP-1. J Biol Chem (2002) 1.30
Ternary oxovanadium(IV) complexes of ONO-donor Schiff base and polypyridyl derivatives as protein tyrosine phosphatase inhibitors: synthesis, characterization, and biological activities. J Biol Inorg Chem (2009) 1.28
Exploration of α-aminophosphonate N-derivatives as novel, potent and selective inhibitors of protein tyrosine phosphatases. Eur J Med Chem (2012) 1.26
PTP-MEG2 is activated in polycythemia vera erythroid progenitor cells and is required for growth and expansion of erythroid cells. Blood (2003) 1.24
Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation. Nat Commun (2011) 1.23
Mononuclear copper(II) complexes with 3,5-substituted-4-salicylidene-amino-3,5-dimethyl-1,2,4-triazole: synthesis, structure and potent inhibition of protein tyrosine phosphatases. Dalton Trans (2011) 1.17
AP-1 activated by toll-like receptors regulates expression of IL-23 p19. J Biol Chem (2009) 1.17
Berberine suppresses androgen receptor signaling in prostate cancer. Mol Cancer Ther (2011) 1.11
Synthesis, characterization, solid-state photo-luminescence and anti-tumor activity of zinc(II) 4'-phenyl-terpyridine compounds. J Inorg Biochem (2010) 1.09
Trans-regulation of histone deacetylase activities through acetylation. J Biol Chem (2009) 1.06
Death receptor 6 induces apoptosis not through type I or type II pathways, but via a unique mitochondria-dependent pathway by interacting with Bax protein. J Biol Chem (2012) 1.01
Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer. PLoS One (2012) 1.00
Mitochondrial uncoupling inhibits p53 mitochondrial translocation in TPA-challenged skin epidermal JB6 cells. PLoS One (2010) 0.98
Synthesis and evaluation of oxovanadium(IV) complexes of Schiff-base condensates from 5-substituted-2-hydroxybenzaldehyde and 2-substituted-benzenamine as selective inhibitors of protein tyrosine phosphatase 1B. Dalton Trans (2012) 0.98
Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformation. J Cell Biochem (2011) 0.96
Cardioprotective effects of salvianolic Acid a on myocardial ischemia-reperfusion injury in vivo and in vitro. Evid Based Complement Alternat Med (2011) 0.96
Synthesis, characterization, and protein tyrosine phosphatases inhibition activities of oxovanadium(IV) complexes with Schiff base and polypyridyl derivatives. J Inorg Biochem (2010) 0.96
Potentiation of Th17 cytokines in aging process contributes to the development of colitis. Cell Immunol (2010) 0.96
20(S)-protopanaxadiol-aglycone downregulation of the full-length and splice variants of androgen receptor. Int J Cancer (2012) 0.95
Antagonism or synergism. Role of tyrosine phosphatases SHP-1 and SHP-2 in growth factor signaling. J Biol Chem (2006) 0.95
Design, synthesis, bioactivity, and structure-activity relationship (SAR) studies of novel benzoylphenylureas containing oxime ether group. J Agric Food Chem (2008) 0.95
Characterization of a highly effective protein substrate for analysis of JAK2(V617F) Activity. Exp Hematol (2007) 0.94
Tyrosine phosphatase MEG2 modulates murine development and platelet and lymphocyte activation through secretory vesicle function. J Exp Med (2005) 0.94
SPAP2, an Ig family receptor containing both ITIMs and ITAMs. Biochem Biophys Res Commun (2002) 0.93
Specific interaction of protein tyrosine phosphatase-MEG2 with phosphatidylserine. J Biol Chem (2003) 0.93
Clinical translation of folate receptor-targeted therapeutics. Expert Opin Drug Deliv (2012) 0.92
Relevance of JAK2V617F positivity to hematological diseases--survey of samples from a clinical genetics laboratory. J Hematol Oncol (2011) 0.92
Cardiac hypertrophy associated with myeloproliferative neoplasms in JAK2V617F transgenic mice. J Hematol Oncol (2014) 0.88
Acetylation of histone deacetylase 1 regulates NuRD corepressor complex activity. J Biol Chem (2012) 0.88
JAK2V617F and p53 mutations coexist in erythroleukemia and megakaryoblastic leukemic cell lines. Exp Hematol Oncol (2012) 0.87
Low nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression. Kidney Int (2013) 0.87
Detection of the JAK2V617F mutation by asymmetric PCR and melt curve analysis. Cancer Biomark (2007) 0.86
The Jak2 inhibitor, G6, alleviates Jak2-V617F-mediated myeloproliferative neoplasia by providing significant therapeutic efficacy to the bone marrow. Neoplasia (2011) 0.86
Split Renilla luciferase protein fragment-assisted complementation (SRL-PFAC) to characterize Hsp90-Cdc37 complex and identify critical residues in protein/protein interactions. J Biol Chem (2010) 0.86
p-Aminoacetophenonic acids produced by a mangrove endophyte Streptomyces sp. (strain HK10552). Molecules (2010) 0.86
SU11652 Inhibits tyrosine kinase activity of FLT3 and growth of MV-4-11 cells. J Hematol Oncol (2012) 0.85
Identification of a variant form of tyrosine phosphatase LYP. BMC Mol Biol (2010) 0.85
Blocking the function of tyrosine phosphatase SHP-2 by targeting its Src homology 2 domains. J Biol Chem (2003) 0.85
Synthesis and biological activity of halophenols as potent antioxidant and cytoprotective agents. Bioorg Med Chem Lett (2010) 0.84
Design, synthesis, and insecticidal activities of new N-benzoyl-N'-phenyl-N'-sulfenylureas. J Agric Food Chem (2009) 0.84
Potent inhibition of protein tyrosine phosphatases by copper complexes with multi-benzimidazole derivatives. Biometals (2011) 0.84
Mechanisms by which the antitumor compound di-n-butyl-di-(4-chlorobenzohydroxamato)tin(IV) induces apoptosis and the mitochondrial-mediated signaling pathway in human cancer SGC-7901 cells. Mol Carcinog (2010) 0.83
Occurrence of endocrine-disrupting compounds in reclaimed water from Tianjin, China. Anal Bioanal Chem (2005) 0.83
Effects of incorporation of nano-fluorapatite or nano-fluorohydroxyapatite on a resin-modified glass ionomer cement. Acta Biomater (2010) 0.82
Structure elucidation of five new iridoid glucosides from the leaves of Avicennia marina. Magn Reson Chem (2008) 0.82
Aconitase regulation of erythropoiesis correlates with a novel licensing function in erythropoietin-induced ERK signaling. PLoS One (2011) 0.82
Tyrosine phosphorylation of phospholipase D1 by v-Src does not per se result in activation. Cell Signal (2005) 0.82
Transposon mutagenesis reveals cooperation of ETS family transcription factors with signaling pathways in erythro-megakaryocytic leukemia. Proc Natl Acad Sci U S A (2013) 0.82
Synthesis and antitumor activity of a new mixed-ligand complex di-n-butyl-(4-chlorobenzohydroxamato)tin(IV) chloride. J Inorg Biochem (2008) 0.81
Chemopreventive effects of Peucedanum praeruptorum DUNN and its major constituents on SGC7901 gastric cancer cells. Molecules (2010) 0.81
Long-acting formulation of a new muscarinic receptor antagonist for the treatment of overactive bladder. J Microencapsul (2012) 0.81
New A-nor steroids and their antifouling activity from the Chinese marine sponge Acanthella cavernosa. Steroids (2008) 0.81
PSAP induces a unique Apaf-1 and Smac-dependent mitochondrial apoptotic pathway independent of Bcl-2 family proteins. Biochim Biophys Acta (2012) 0.80
The adenylyl cyclase inhibitor MDL-12,330A potentiates insulin secretion via blockade of voltage-dependent K(+) channels in pancreatic beta cells. PLoS One (2013) 0.80
Nonionic surfactant vesicles for delivery of RNAi therapeutics. Nanomedicine (Lond) (2013) 0.80
Identification of a variant form of PZR lacking immunoreceptor tyrosine-based inhibitory motifs. Biochem Biophys Res Commun (2003) 0.80
Syntheses, molecular structures, electrochemical behavior, theoretical study, and antitumor activities of organotin(IV) complexes containing 1-(4-chlorophenyl)-1-cyclopentanecarboxylato ligands. Inorg Chem (2011) 0.80
Synthesis of a small library of diketopiperazines as potential inhibitors of calpain. Bioorg Med Chem Lett (2005) 0.79
Generation and characterization of a highly effective protein substrate for analysis of FLT3 activity. J Hematol Oncol (2012) 0.79
Deformable liposomes by reverse-phase evaporation method for an enhanced skin delivery of (+)-catechin. Drug Dev Ind Pharm (2013) 0.79
Tyrosine phosphatases SHP-1 and SHP-2 are associated with distinct tyrosine-phosphorylated proteins. Exp Cell Res (2002) 0.79
Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres. Int J Pharm (2010) 0.79
Beneficial and harmful effects of alcohol exposure on Caenorhabditis elegans worms. Biochem Biophys Res Commun (2011) 0.78
Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere. Chem Pharm Bull (Tokyo) (2009) 0.78
Tea contains potent inhibitors of tyrosine phosphatase PTP1B. Biochem Biophys Res Commun (2011) 0.78
Development of liposomal Ginsenoside Rg3: formulation optimization and evaluation of its anticancer effects. Int J Pharm (2013) 0.78